Upstream stimulatory factor-2 mediates quercetin-induced suppression of PAI-1 gene expression in human endothelial cells

Journal of Cellular Biochemistry

Volumn 111, Issue 3, 2010, Pages 720-726

  Olave, Nélida C ^a   Grenett, Maximiliano H ^a   Cadeiras, Martin ^a   Grenett, Hernan E ^a   Higgins, Paul J ^b  

^a University of Alabama at Birmingham   (United States)

^b ALBANY MEDICAL COLLEGE   (United States)

Author keywords

Endothelial Cells; PAI 1; Proliferation; Transcription Factor; Transfection; USF

Indexed keywords

BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; COMPLEMENTARY DNA; LUCIFERASE; MYC PROTEIN; NUCLEOTIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; QUERCETIN; UPSTREAM STIMULATORY FACTOR 1; UPSTREAM STIMULATORY FACTOR 2;

ARTICLE; CELL PROLIFERATION; DRUG PROTEIN BINDING; E BOX ELEMENT; ENDOTHELIUM CELL; EXPRESSION VECTOR; GEL MOBILITY SHIFT ASSAY; GENE CONSTRUCT; GENE DELETION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION;

CARDIOTONIC AGENTS; CELL PROLIFERATION; CELLS, CULTURED; DOWN-REGULATION; E-BOX ELEMENTS; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; LEUCINE ZIPPERS; PEPTIDE FRAGMENTS; PLASMINOGEN ACTIVATOR INHIBITOR 1; QUERCETIN; UPSTREAM STIMULATORY FACTORS;

EID: 78651314079     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22760     Document Type: Article

References (42)

1. Abou-Agag LH, Aikens ML, Tabengwa EM, Benza RL, Shows SR, Grenett HE, Booyse FM. 2001. Polyphyenolics increase t-PA and u-PA gene transcription in cultured human endothelial cells. Alcohol Clin Exp Res 25:155-162.
2. Alcocer F, Whitley D, Salazar-Gonzalez JF, Jordan WD, Sellers MT, Eckhoff DE, Suzuki K, Macrae C, Bland KI. 2002. Quercetin inhibits human vascular smooth muscle cell proliferation and migration. Surgery 131:198-204.
3. Alessi MC, Juhan-Vague I. 2008. Metabolic syndrome, haemostasis and thrombosis. Thromb Haemost 99:995-1000.
4. Allen RR, Qi L, Higgins PJ. 2005. Upstream stimulatory factor regulates E Box-dependent PAI-1 transcription in human epidermal keratinocytes. J Cell Physiol 203:156-165.
5. Aperlo C, Boulukos KE, Pognonec P. 1996. The basic region/helix- loophelix/leucine repeat transcription factor USF interferes with Ras transformation. Eur J Biochem 241:249-253.
6. Bruno ME, West RB, Schneeman TA, Bresnick EH, Kaetzel CS. 2004. Upstream stimulatory factor but not c-Myc enhances transcription of the human polymeric immunoglobulin receptor gene. Mol Immunol 40:695-708.
7. Chen Y, Budd RC, Kelm RJ, Jr., Sobel BE, Schneider DJ. 2006. Augmentation of proliferation of vascular smooth muscle cells by plasminogen activator inhibitor type 1. Arterioscler Thromb Vasc Biol 26:1777-1783.
8. Cheung E, Mayr P, Coda-Zabetta F, Woodman PG, Boam DS. 1999. DNAbinding activity of the transcription factor upstream stimulatory factor 1 (USF-1) is regulated by cyclin-dependent phosphorylation. Biochem J 344:145-152.
9. Corre S, Galibert MD. 2005. Upstream stimulating factors: Highly versatile stress-responsive transcription factors. Pigment Cell Res 18:337-348.
10. DeYoung MB, Tom C, Dichek DA. 2001. Plasminogen activator inhibitor type 1 increases neointima formation in balloon-injured rat carotid arteries. Circulation 104:1972-1977.
11. Dimova EY, Kietzmann T. 2006. Cell type-dependent regulation of the hypoxia-responsive plasminogen activator inhibitor-1 gene by upstream stimulatory factor-2. J Biol Chem 281:2999-3005.
12. Fan PS, Gu ZL, Sheng R, Liang ZQ, Wang XX, Zhu Y. 2003. Inhibitory effect of quercetin on proliferation of human microvascular endothelial cells in vitro. Acta Pharmacol Sin 24:1231-1234.
13. Farr A, Roman A. 1992. A pitfall of using a second plasmid to determine transfection efficiency. Nucleic Acids Res 20:920-922.
14. Fresco P, Borges F, Diniz C, Marques MP. 2006. New insights on the anticancer properties of dietary polyphenols. Med Res Rev 26:747-766.
15. Grenett HE, Benza RL, Fless GM, Li XN, Davis GC, Booyse FM. 1998a. Genotype-specific transcriptional regulation of PAI-1 gene expression by insulin, hypertriglyceridemic VLDL, Lp(a) in transfected cultured human endothelial cells. Arterioscler Thromb Vasc Biol 18:1803-1809.
16. Grenett HE, Aikens ML, Torres JA, Demissie S, Tabengwa EM, Davis GC, Booyse FM. 1998b. Ethanol transcriptionally upregulates t-PA and u-PA gene expression in cultured human endothelial cells. Alcohol Clin Exp Res 22:849-853.
17. Grenett HE, Aikens ML, Tabengwa EM, Davis GC, Booyse FM. 2000. Ethanol downregulates transcription of the PAI-1 gene in cultured human endothelial cells. Thromb Res 97:247-255.
18. Grenett HE, Wolkowicz PE, Benza RL, Tresnak JK, Wheeler CG, Booyse FM. 2001. Identification of a 251-bp fragment of the PAI-1 gene promoter that mediates the ethanol-induced suppression of PAI-1 expression. Alcohol Clin Exp Res 25:629-636.
19. Hertog MG, Feskens EJ, Hollman PC, Katan MB, Kromhout D. 1993. Dietary antioxidant flavonoids and risk of coronary heart disease: The Zutphen Elderly Study. Lancet 342:1007-1011.
20. Ismail PM, Lu T, Sawadogo M. 1999. Loss of USF transcriptional activity in breast cancer cell lines. Oncogene 18:5582-5591.
21. Jung HS, Kim KS, Chung YJ, Chung HK, Min YK, Lee MS, Lee MK, Kim KW, Chung JH. 2007. USF inhibits cell proliferation through delay in G2/M phase in FRTL-5 cells. Endocr J 54:275-285.
22. Kaikita K, Fogo AB, Ma L, Schoenhard JA, Brown NJ, Vaughan DE. 2001. Plasminogen activator inhibitor-1 deficiency prevents hypertension and vascular fibrosis in response to long-term nitric oxide synthase inhibition. Circulation 104:839-844.
23. Knekt P, Ritva J, Antti R, Jouni M. 2001. Flavoid intake and coronary mortality in Finland: A Cohort Study. Br Med J 312:478-481.
24. Kortlever RM, Higgins PJ, Bernards R. 2006. Plasminogen activator inhibitor- 1 is a critical downstream target of p53 in the induction of replicative senescnce. Nature Cell Biol 8:877-884.
25. Lorenz WW, Cormier MJ, O'Kane DJ, Hua D, Escher AA, Szalay AA. 1996. Expression of the Renilla reniformis luciferase gene in mammalian cells. J Biolumin Chemilumin 11:31-37.
26. Luo X, Sawadogo M. 1996. Antiproliferative properties of the USF family of helix-loop-helix transcription factors. Proc Natl Acad Sci USA 93:1308-1313.
27. Ma Z, Jhun B, Oh CK. 2007. Upstream stimulating factor-1 mediates the E-box-dependent transcriptional repression of the plasminogen activator inhibitor-1 gene in human mast cells. FEBS Lett 581:4485-4490.
28. Massari ME, Murre C. 2000. Helix-loop-helix proteins: Regulators of transcription in eucaryotic organisms. Mol Cell Biol 20:429-440.
29. Pan W, Chang MJ, Booyse FM, Grenett HE, Bradley KM, Wolkowicz PE, Shang Q, Tabengwa EM. 2008. Quercetin induced tissue-type plasminogen activator expression is mediated through Sp1 and p38 mitogen-activated protein kinase in human endothelial cells. J Thromb Haemost 6:976-985.
30. Pandolfi A, Cetrullo D, Polishuck R, Alberta MM, Calafiore A, Pellegrini G, Vitacolonna E, Capani F, Consoli A. 2001. Plasminogen activator inhibitor type 1 is increased in the arterial wall of type II diabetic subjects. Arterioscler Thromb Vasc Biol 21:1378-1382.
31. Pasten C, Olave NC, Zhou L, Tabengwa EM, Wolkowicz PE, Grenett HE. 2007. Polyphenols downregulate PAI-1 gene expression in cultured human coronary artery endothelial cells: Molecular contributor to cardiovascular protection. Thromb Res 121:59-65.
32. Providence KM, White LA, Tang J, Gonclaves J, Staiano-Coico L, Higgins PJ. 2002. Epithelial monolayer wounding stimulates binding of USF-1 to an Ebox motif in the plasminogen activator inhibitor type 1 gene. J Cell Sci 115:3767-3777.
33. Qi L, Allen RR, Lu Q, Higgins CE, Garone R, Staiano-Coico L, Higgins PJ. 2006. PAI-1 transcriptional regulation during the G0!G1 transition in human epidermal keratinocytes. J Cell Biochem 99:495-507.
34. Qyang Y, Luo X, Lu T, Ismail PM, Krylov D, Vinson C, Sawadogo M. 1999. Cell-type-dependent activity of the ubiquitous transcription factor USF in cellular proliferation and transcriptional activation. Mol Cell Biol 19:1508-1517.
35. Samarakoon R, Higgins PJ. 2008. Integration of non-SMAD and SMAD signaling in TGF-b1-induced plasminogen activator inhibitor type-1 gene expression in vascular smooth muscle cells. Thromb Haemost 100:976-983.
36. Samoylenko A, Roth U, Jungermann K, Kietzmann T. 2001. The upstream stimulatory factor-2a inhibits plasminogen activator inhibitor-1 gene expression by binding to a promoter element adjacent to the hypoxiainducible factor-1 binding site. Blood 97:2657-2666.
37. Sawadogo M, Roeder RG. 1985. Interaction of a gene-specific transcription factor with the adenovirus major late promoter upstream of the TATA box region. Cell 43:165-175.
38. Sirito M, Lin Q, Maity T, Sawadogo M. 1994. Ubiquitous expression of the 43- and 44-kDa forms of transcription factor USF in mammalian cells. Nucleic Acids Res 22:427-433.
39. Szentirmay MN, Yang HX, Pawar SA, Vinson C, Sawadogo M. 2003. The IGF2 receptor is a USF2-specific target in nontumorigenic mammary epithelial cells but not in breast cancer cells. J Biol Chem 278:37231-37240.
40. Viollet B, Lefrancois-Martinez AM, Henrion A, Kahn A, Raymondjean M, Martinez A. 1996. Immunochemical characterization and transacting properties of upstream stimulatory factor isoforms. J Biol Chem 271:1405-1415.
41. Westrick RJ, Eitzman DT. 2007. Plasminogen activator inhibitor-1 in vascular thrombosis. Curr Drug Targets 8:966-1002.
42. Wu Q, Zhao Z. 2002. Inhibition of PAI-1: A new anti-thrombotic approach.